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Abstract Exposure of PC12 cells to 100 WM peroxynitrite
promotes phosphorylation of extracellular signal-regulated ki-
nases 1 and 2 (ERK1/2) sensitive to PD98059 or U0126. At
higher concentrations, however, ERK1/2 phosphorylation was
prevented by U0126 and increased by PD98059 via a U0126-
sensitive mechanism. PD98059, unlike U0126, enhanced the
peroxynitrite-dependent formation of reactive oxygen species
(ROS). These results, along with others obtained using respira-
tory chain inhibitors and respiration-de¢cient cells, lead to the
conclusion that PD98059, while e¡ectively inhibiting the per-
oxynitrite-induced Raf/MEK signaling leading to ERK1/2 phos-
phorylation, promotes an enforced mitochondrial formation of
ROS inducing ERK1/2 phosphorylation via a Raf-1-indepen-
dent/MEK-dependent mechanism.
3 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Peroxynitrite, a powerful biological oxidant, e¡ectively
stimulates the phosphorylation of the extracellular signal-
regulated kinase (ERK) isoforms p44 (ERK1) and p42
(ERK2) in di¡erent cell types [1^4]. In rat pulmonary myo¢-
broblasts peroxynitrite, as well as H2O2, activates the epider-
mal growth factor receptor (EGRF), Raf-1 and mitogen-acti-
vated protein kinase kinase (MEK) but, unlike H2O2, induces
these e¡ects independently so that ERK phosphorylation was
also observed when the EGRF tyrosine kinase or Raf-1 kinase
was blocked [2]. Zouki et al. [4] found that peroxynitrite acti-
vates ERK via the Ras/Raf/MEK signaling cascade also in
human neutrophils. A di¡erent study [3] showed that the per-
oxynitrite-dependent activation of ERK1/2 in rat-1 ¢broblasts
is mediated by protein kinase C (most likely a calcium-depen-
dent isoform) in a MEK-independent manner. Thus, it ap-
pears that di¡erent pathways are involved in the activation
of ERK1/2 phosphorylation induced by peroxynitrite in dif-
ferent cell types. Not surprisingly, PD98059 inhibited ERK1/2
phosphorylation induced by peroxynitrite in rat pulmonary
myo¢broblasts [2] or human neutrophils [4] but was ine¡ective
in rat-1 ¢broblasts [3].
We herein report experimental evidence of a novel e¡ect of
PD98059 in cells exposed to peroxynitrite. In PC12 cells, the
oxidant appears to stimulate ERK1/2 phosphorylation via a
MEK-dependent mechanism that can be prevented by
PD98059. Under the same conditions, however, the inhibitor
greatly enhances the peroxynitrite-dependent mitochondrial
formation of reactive oxygen species (ROS) promoting
ERK1/2 phosphorylation via a MEK-dependent, Raf-1-inde-
pendent mechanism. Thus, under conditions of combined ex-
posure to PD98059 and peroxynitrite the extent of ERK1/2
phosphorylation is much greater than that mediated by per-
oxynitrite alone.
2. Materials and methods
2.1. Cell culture and treatments
PC12 rat pheochromocytoma respiration-pro¢cient and -de¢cient
cells were cultured as previously described [5]. For experiments, cells
(2.5U105) were inoculated into 60 mm tissue culture dishes and grown
for 18^24 h. At the treatment stage, total cell number was between 4.0
and 4.5U105 cells/dish. Treatments were performed in 2 ml of saline
A (8.182 g/l NaCl, 0.372 g/l KCl, 0.336 g/l NaHCO3 and 0.9 g/l
glucose) at 37‡C. Peroxynitrite was synthesized as previously de-
scribed [6] and added to the cultures as a bolus. PD98059 and
U0126 (Alexis Biochemicals, Florence, Italy) were dissolved in di-
methyl sulfoxide; at the treatment stage the ¢nal concentration of
dimethyl sulfoxide was never higher than 0.05%.
2.2. Western blot analysis
Following treatments, cells were washed twice with phosphate-bu¡-
ered saline, scraped into ice-cold lysis bu¡er (50 mM Tris, 5 mM
EDTA, 150 mM NaCl, 0.5% Nonidet P-40, 1 mM phenylmethylsul-
fonyl £uoride, 1 mM sodium vanadate and 1 mM sodium £uoride, pH
8.0) and incubated on ice for 1 h. Cells were then sonicated and
centrifuged for 10 min at 21 500Ug (4‡C). Supernatants were assayed
for protein concentration using Bio-Rad protein assay reagent. Pro-
tein samples (25 Wg) were resolved by sodium dodecyl sulfate^polyac-
rylamide gel electrophoresis on a 10% polyacrylamide gel and electro-
transferred to polyvinylidene di£uoride membranes. The blots were
blocked for 1 h at room temperature with 5% milk powder in Tris-
bu¡ered saline (140 mM NaCl, 50 mM Tris^HCl, pH 7.2) containing
0.06% Tween 20 and probed with a primary antibody against phos-
pho-ERK1/2 (1:700) or ERK1/2 (1:1000) overnight at 4‡C. Horse-
radish peroxidase-conjugated monoclonal or polyclonal antibodies
(1:2000) were used for enhanced chemiluminescence detection. The
antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Densitometric analysis of blots was performed using
the electrophoresis documentation and the public domain NIH Image
0014-5793 / 03 / $22.00 L 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
doi:10.1016/S0014-5793(03)00675-6
*Corresponding author. Fax: (39)-0722-327670.
E-mail address: cantoni@uniurb.it (O. Cantoni).
Abbreviations: ERK1/2, extracellular signal-regulated kinases 1 and
2; EGRF, epidermal growth factor receptor; MEK, MAPK/ERK
kinase; ROS, reactive oxygen species; FBS, fetal bovine serum;
DHR, dihydrorhodamine 123
FEBS 27426 3-7-03
FEBS 27426FEBS Letters 547 (2003) 92^96
1.62 program (developed at the US National Institutes of Health and
available on Internet at http://rsb.info.nih.gov/nih-image/).
2.3. Oxidation of dihydrorhodamine
The cells were treated and then loaded with 10 WM dihydrorhod-
amine 123 (DHR, Molecular Probes Europe, Leiden, The Nether-
lands) for 10 min in saline A containing 5% fetal bovine serum
(FBS) at 37‡C. After accurate washes cellular £uorescence was imaged
and quanti¢ed as previously described [5].
2.4. Statistical analysis
The results are expressed as meansPS.E.M.; statistical analysis of
the data for multiple comparisons was performed by the analysis of
variance followed by Dunnett’s test.
3. Results and discussion
In keeping with previous ¢ndings from other laboratories,
exposure of PC12 cells to KCl (75 WM, [7]), FBS (20% [8]),
H2O2 (1 mM [9]) or peroxynitrite (500 WM [1]) resulted in
increased ERK1/2 phosphorylation, whereas no change in
the amount of ERK proteins was observed (Fig. 1A,B). Phos-
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Fig. 1. The e¡ect of PD98059 or U0126 on ERK1/2 phosphorylation induced by peroxynitrite and other stimuli. A: Cells were exposed for
10 min to 50 WM PD98059 or 20 WM U0126, and subsequently treated with 75 mM KCl (5 min), 20% FBS (10 min) or 1 mM H2O2 (10 min).
Cell were then lysed for Western blot analysis using antibodies recognizing phospho- and total ERK proteins. B: Cells pre-exposed (10 min) to
the ERK inhibitors (see above) and treated for a further 15 min with 500 WM peroxynitrite were analyzed as detailed in A. C: Cells pre-ex-
posed (10 min) to the ERK inhibitors and then treated with 500 WM peroxynitrite for 15 min in fresh saline in the absence of the ERK inhibi-
tors were processed for Western blot analysis using phospho-ERK antibodies (top). The blot shown at the bottom reports the results of an ex-
periment in which the cells were treated for 5 min with 500 WM peroxynitrite and then post-incubated for a further 10 min in the presence of
either PD98059 or U0126. D: Cells pre-exposed to PD98059 for 10 min were treated for an additional 15 min with increasing concentrations
of peroxynitrite and then analyzed as detailed in C. Fold increase in ERK1/2 activation is shown below each lane of the blot. Each of the blots
shown above (A^D) is representative of at least ¢ve experiments with similar outcomes.
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phorylation of ERK1/2 induced by the above di¡erent stimuli
seems to require MEK since this response was abolished by
U0126 (20 WM), which inhibits MEK activation and activity
[10]. Surprisingly, however, PD98059 (50 WM), which binds
directly to the non-phosphorylated form of MEK after block-
ing its activation by Raf-1 [10], markedly reduced ERK1/2
phosphorylation induced by KCl, FBS and H2O2 but actually
enhanced phosphorylation induced by peroxynitrite. Impor-
tantly, U0126 suppressed ERK1/2 phosphorylation induced
by the cocktail PD98059/peroxynitrite (Fig. 1B).
Thus, these results on the one hand con¢rm that KCl, FBS
and H2O2 activate ERK1/2 and that U0126 more potently
than PD98059 inhibits these responses [10] whereas, on the
other hand, they provide unexpected experimental evidence
suggesting that PD98059 does not inhibit but, rather, enhan-
ces the peroxynitrite-induced ERK1/2 phosphorylation. The
observation that the latter response is sensitive to U0126 is
consistent with an involvement of MEK, which must be acti-
vated via a Raf-1-independent mechanism. These results were
reproducibly obtained using 10 di¡erent preparations of per-
oxynitrite and four lots of PD98059. Furthermore, decom-
posed peroxynitrite, or the vehicle, failed to stimulate
ERK1/2 phosphorylation produced by peroxynitrite both in
the absence and in the presence of PD98059 (not shown). It is
important to note that peroxynitrite was used at 500 WM, a
condition failing to produce obvious signs of toxicity detect-
able by visual inspection or by the trypan blue exclusion/lac-
tate dehydrogenase assays (not shown). Other studies inves-
tigating ERK1/2 phosphorylation employed similar, or higher,
concentrations of peroxynitrite [1,2].
In an attempt to further characterize the e¡ects of
PD98059, we performed experiments in which the cells were
incubated for 10 min with the inhibitor and then, after accu-
rate washing, exposed for a further 15 min to peroxynitrite.
As illustrated in Fig. 1C (top) this regimen also caused en-
hanced ERK1/2 phosphorylation. However, PD98059 added
to the cultures 5 min after peroxynitrite, a time at which the
oxidant is already decomposed [11], caused inhibition of phos-
phorylation (Fig. 1C, bottom). Thus PD98059, in order to
mediate enhanced ERK1/2 phosphorylation, must be within
the cells at the time of peroxynitrite exposure. An additional
conclusion from these experiments is that peroxynitrite, con-
sistently with previously published data [2,4], promotes
ERK1/2 phosphorylation via a Raf-1-dependent mechanism.
We next investigated the e¡ect of increasing concentrations of
peroxynitrite and found that ERK1/2 phosphorylation was
clearly detectable at 100 WM and dose-dependent up to
500 WM (Fig. 1D). Interestingly, the enhancing e¡ects of
PD98059 were noted when this treatment was combined
with peroxynitrite levels greater than 100 WM whereas, at
this concentration, inhibition was rather observed. We inter-
pret these ¢ndings as an indication that concentrations of
peroxynitrite higher than 100 WM are required to promote,
when associated with PD98059, a Raf-1-independent ERK1/
2 phosphorylation.
The £uorescent probe DHR, which accumulates in the mi-
tochondria and £uoresces when oxidized by various species,
was utilized to obtain biochemical evidence of delayed ROS
formation in PC12 cells exposed to peroxynitrite. In these
experiments, the cells were treated with 500 WM peroxynitrite
for 5 min, exposed for an additional 10 min to 10 WM DHR
and ¢nally examined by confocal microscopy. Under these
conditions, peroxynitrite, which readily decomposes after its
addition to the cultures [11], cannot directly oxidize DHR.
The oxidant caused a slight, although statistically signi¢cant,
increase in the £uorescence response (Fig. 2A) sensitive to the
peroxynitrite scavengers L-methionine (20 mM) and Trolox
(1 mM) (not shown). Pre-exposure to U0126 did not a¡ect
basal £uorescence or the ability of peroxynitrite to promote
oxidation of DHR. In contrast, not only did PD98059 gener-
ate a £uorescence response in the absence of additional treat-
ments but, most importantly, it dramatically increased the
delayed oxidation of DHR mediated by peroxynitrite. It is
unclear whether the e¡ect of PD98059 alone is due to forma-
tion of ROS or to the intrinsic £uorescence of the compound.
Although further investigation is needed to address this issue,
we favor the second possibility since time dependence studies
indicated that oxidation of DHR remains stable after addition
of the inhibitor but progressively increases upon supplemen-
tation with peroxynitrite (not shown). Thus, the ability of
PD98059 to increase ROS formation after exposure to per-
oxynitrite may explain its e¡ects on ERK1/2 phosphorylation,
which are remarkably di¡erent from those mediated by
U0126. It is indeed well established that ROS are e¡ective
inducers of ERK1/2 phosphorylation [12].
Peroxynitrite promotes important e¡ects at the level of the
mitochondrial respiratory chain and, among these, we previ-
ously identi¢ed delayed formation of superoxides and H2O2
as a consequence of the peroxynitrite-dependent inhibition of
complex III [13]. We reasoned that PD98059 might enhance
this response thereby promoting a £ux of ROS responsible for
ERK1/2 phosphorylation. The results illustrated in Fig. 2B
are consistent with this notion since the complex I inhibitor
rotenone, at a concentration (0.5 WM) suppressing oxygen
consumption [5,13], also caused inhibition of ERK1/2 phos-
phorylation mediated by PD98059/peroxynitrite but did not
a¡ect the response elicited by peroxynitrite alone. Similarly,
rotenone failed to prevent ERK1/2 phosphorylation induced
by FBS (Fig. 2C). Since rotenone suppressed delayed ROS
formation mediated by peroxynitrite, both in the absence
and in the presence of PD98059 (Fig. 2A), we conclude that
mitochondrial ROS are involved in ERK1/2 phosphorylation
induced by PD98059/peroxynitrite, but not by peroxynitrite
alone.
Peroxynitrite e¡ectively stimulates ERK1/2 phosphoryla-
tion also in respiration-de¢cient cells (Fig. 2D) and this re-
sponse, while not a¡ected by rotenone (not shown), is signi¢-
cantly reduced by U0126 as well as by PD98059. In these
cells, peroxynitrite (with or without PD98059) failed to pro-
mote formation of superoxides or H2O2 (not shown) and, as a
consequence, the notion that ROS are not involved in ERK1/
2 phosphorylation mediated by peroxynitrite is further estab-
lished. In addition, the observation that under conditions not
permissive for ROS formation PD98059 inhibits ERK1/2
phosphorylation mediated by peroxynitrite on the one hand
emphasizes the speci¢city of the e¡ects of the MEK inhibitor
and, on the other hand, demonstrates that a functional respi-
ratory chain is required in order for peroxynitrite and
PD98059 to promote formation of ROS responsible for
ERK1/2 phosphorylation.
In conclusion, our ¢ndings indicate that peroxynitrite pro-
motes PC12 cell ERK1/2 phosphorylation mediated by a Raf-
MEK-dependent mechanism. Consistently, the response elic-
ited by low peroxynitrite concentrations (100 WM) was inhib-
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ited by either U0126 or PD98059. PD98059 also inhibited the
pathway leading to Raf/MEK/ERK1/2 phosphorylation trig-
gered by higher concentrations of peroxynitrite but, under
these conditions, promoted parallel events causing enforced
mitochondrial formation of ROS responsible for the activa-
tion of a Raf-1-independent pathway resulting in MEK/
ERK1/2 phosphorylation. In order to produce these e¡ects,
PD98059 has to be given to the cultures at the time of per-
oxynitrite exposure and acted as an inhibitor of ERK phos-
phorylation when added after peroxynitrite. Importantly,
PD98059 inhibited ERK phosphorylation in respiration-de¢-
cient cells also under conditions of concomitant exposure with
peroxynitrite.
As stated above, peroxynitrite was not toxic for the cells in
the absence of additional treatments. The question therefore
arises as to whether activation of ERK1/2 plays a role in
survival and, if this is the case, then the above observations
lead to the possibility that PD98059 and U0126 di¡erentially
impact on cell survival. Furthermore, it may be expected that
PD98059 promotes di¡erent e¡ects in cells exposed to 100
WM, or higher, concentrations of peroxynitrite. As a ¢nal
note, our results indicate PD98059 should be carefully utilized
as a MEK inhibitor, in particular under conditions involving
exposure to either authentic peroxynitrite or agents resulting
in the formation of endogenous peroxynitrite.
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